Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Akebia Therapeutics (AKBA)

Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Akebia Therapeutics: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Akebia Therapeutics: Q3 Earnings Snapshot

AKBA : 1.3850 (+1.84%)
Akebia Therapeutics Announces Five Poster Presentations at ASN Kidney Week 2023 PR Newswire - Wed Oct 18, 2023

/PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...

AKBA : 1.3850 (+1.84%)
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire - Tue Oct 3, 2023

/PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...

AKBA : 1.3850 (+1.84%)
Akebia Therapeutics Resubmits New Drug Application to the FDA for Vadadustat PR Newswire - Thu Sep 28, 2023

/PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...

AKBA : 1.3850 (+1.84%)
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...

AKBA : 1.3850 (+1.84%)
Gap, Hibbett rise; Hawaiian Electric, Nordstrom fall, Friday, 8/25/2023 Associated Press - Fri Aug 25, 2023

Stocks that are trading heavily or have substantial price changes Friday: Gap, Hibbett rise; Hawaiian Electric, Nordstrom fall

JWN : 19.79 (+5.32%)
DOMO : 7.59 (+1.61%)
WDAY : 257.74 (+1.66%)
AKBA : 1.3850 (+1.84%)
GPS : 20.94 (+0.92%)
HE : 11.08 (+2.31%)
Akebia Therapeutics: Q2 Earnings Snapshot AP - Fri Aug 25, 2023

Akebia Therapeutics: Q2 Earnings Snapshot

AKBA : 1.3850 (+1.84%)
Akebia Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights PR Newswire - Fri Aug 25, 2023

/PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...

AKBA : 1.3850 (+1.84%)
Akebia Therapeutics Expects to Resubmit Vadadustat NDA in Third Quarter 2023 PR Newswire - Thu Aug 24, 2023

/PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...

AKBA : 1.3850 (+1.84%)
Akebia Therapeutics to Report Second Quarter Financial Results and Discuss Recent Business Highlights PR Newswire - Wed Aug 23, 2023

/PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...

AKBA : 1.3850 (+1.84%)

Barchart Exclusives

Rev Up Your Portfolio With This Auto Stock Barchart - 54 minutes ago
With a major growth engine in the form of its fleet business, and a dominant footing in the domestic truck business, this underperforming auto stock looks poised to accelerate in the back half of the decade. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot